Cochrane · systematic review · CD005341

Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction

Estcourt, LJ, Stanworth, SJ, Doree, C, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
6
No studies
1
Included studies
NR
No studies 1 · 14.3%Ungraded 0 · 0%Very low 4 · 57.1%Low 2 · 28.6%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Comparison

Population: people with neutropenia or neutrophil dysfunction
7 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality up to 30 days
RR 0.92 [0.63, 1.36]7 studies · 437 participantsVery low
Downgraded: risk of bias, imprecision
Mortality due to infection up to 30 days
RR 0.69 [0.33, 1.44]6 studies · 286 participantsVery low
Downgraded: risk of bias, imprecision
People with localised or systemic bacterial or fungal infections ‐ low‐dose granulocyte transfusions
RR 0.84 [0.58, 1.2]4 studies · 204 participantsVery low
Downgraded: risk of bias, imprecision
People with localised or systemic bacterial or fungal infections ‐ Intermediate‐dose granulocyte transfusions
RR 0.4 [0.26, 0.63]4 studies · 293 participantsLow
Downgraded: risk of bias
People with bacteraemia or fungaemia
RR 0.45 [0.3, 0.65]9 studies · 609 participantsLow
Downgraded: risk of bias
People with localised bacterial or fungal infection
RR 0.75 [0.5, 1.14]6 studies · 296 participantsVery low
Downgraded: risk of bias, imprecision
People with serious adverse events
no estimate extractedNRNo studies